Development and refinement of pregnane X receptor (PXR) DNA binding site model using information theory - Insights into PXR-mediated gene regulation

被引:36
作者
Vyhlidal, CA
Rogan, PK
Leeder, JS
机构
[1] Childrens Mercy Hosp & Clin, Div Pediat Clin Pharmacol & Med Toxicol, Sect Dev Pharmacol & Expt Therapeut, Kansas City, MO 64108 USA
[2] Childrens Mercy Hosp & Clin, Lab Human Mol Genet, Kansas City, MO 64108 USA
关键词
D O I
10.1074/jbc.M408395200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The pregnane X receptor (PXR) acts as a receptor to induce gene expression in response to structurally diverse xenobiotics through binding as a heterodimer with the 9-cis retinoic acid receptor (RXR) to enhancers in target gene promoters. We identified and estimated the affinities of novel PXR/RXR binding sites in regulated genes and additional genomic targets of PXR with an information theory-based model of the PXR/RXR binding site. Our initial PXR/RXR model, the result of the alignment of 15 previously characterized binding sites, was used to scan the promoters of known PXR target genes. Sites from these genes, with information contents of >8 bits bound by PXR/RXR in vitro, were used to revise the information weight matrix; this procedure was repeated by screening for progressively weaker binding sites. After three iterations of refinement, the model was based on 48 validated PXR/RXR binding sites and has an average information content (R-sequence) of 14.43 +/- 3.21 bits. A scan of the human genome predicted novel PXR/RXR binding sites in the promoters of UGT1A3 (19.78 bits at -8040 and 16.37 bits at -6930) and UGT1A6 (12.74 bits at -9216), both of which were identified previously as targets for PXR. These sites were subsequently demonstrated to specifically bind PXR/RXR in competition electrophoretic mobility shift assays. A strong PXR site was also predicted upstream of the CASP10 gene (18.69 bits at -7872) and was validated by binding studies and reporter assays as a PXR responsive element. This suggests that the PXR-mediated response extends beyond genes involved in drug biotransformation and transport.
引用
收藏
页码:46779 / 46786
页数:8
相关论文
共 50 条
[21]   DETERMINANTS FOR SELECTIVE RAR AND TR RECOGNITION OF DIRECT REPEAT HRES [J].
PERLMANN, T ;
RANGARAJAN, PN ;
UMESONO, K ;
EVANS, RM .
GENES & DEVELOPMENT, 1993, 7 (7B) :1411-1422
[22]  
PIERCE JR, 1980, INTRO INFORMATION TH
[23]   Recent advances in computational promoter analysis in understanding the transcriptional regulatory network [J].
Qiu, P .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 309 (03) :495-501
[24]   MatInd and MatInspector: New fast and versatile tools for detection of consensus matches in nucleotide sequence data [J].
Quandt, K ;
Frech, K ;
Karas, H ;
Wingender, E ;
Werner, T .
NUCLEIC ACIDS RESEARCH, 1995, 23 (23) :4878-4884
[25]  
Rae JM, 2001, J PHARMACOL EXP THER, V299, P849
[26]  
Rikhof B, 2003, CANCER BIOL THER, V2, P707
[27]   Information theory-based analysis of CYP2C19, CYP2D6 and CYP3A5 splicing mutations [J].
Rogan, PK ;
Svojanovsky, S ;
Leeder, JS .
PHARMACOGENETICS, 2003, 13 (04) :207-218
[28]  
Rogan PK, 1998, HUM MUTAT, V12, P153, DOI 10.1002/(SICI)1098-1004(1998)12:3<153::AID-HUMU3>3.3.CO
[29]  
2-O
[30]   USING INFORMATION-CONTENT AND BASE FREQUENCIES TO DISTINGUISH MUTATIONS FROM GENETIC POLYMORPHISMS IN SPLICE JUNCTION RECOGNITION SITES [J].
ROGAN, PK ;
SCHNEIDER, TD .
HUMAN MUTATION, 1995, 6 (01) :74-76